TY - JOUR
T1 - Haptoglobin genotype and endothelial function in diabetes mellitus
T2 - A pilot study
AU - Dayan, Lior
AU - Levy, Andrew P.
AU - Blum, Shany
AU - Miller-Lotan, Rachel
AU - Melman, Uzi
AU - Alshiek, Jonia
AU - Jacob, Giris
PY - 2009/7
Y1 - 2009/7
N2 - Endothelial function (EnF) is impaired in patients with diabetes mellitus (DM) due in large part to an increase in oxidative stress. Haptoglobin (Hp) is a potent antioxidant protein which is encoded by two different alleles (1 and 2) with the Hp 1 protein being a superior antioxidant to the Hp 2 protein. We hypothesized that DM individuals with the Hp 2-2 genotype would have greater endothelial dysfunction as compared to DM individuals with the Hp 1-1 genotype. We studied EnF in 16 Hp 2-2, 14 Hp 1-1 DM individuals and 14 healthy subjects. DM patients' groups were matched in terms of age, cardiovascular risk factors and metabolic characteristics. EnF was assessed using post-ischemic reactive hyperemia and strain gauge plethysmography and expressed either as the maximal flow after the ischemic period or as the area under the flow-time curve (AUC). We showed that EnF indices, AUC and maximal flow, were also higher in the healthy and Hp 1-1 groups compared with Hp 2-2 genotype group (615 ± 60 and 600 ± 40 vs. 450 ± 50 ml dl-1, 29 ± 2.6 and 25 ± 3 vs. 14 ± 1.8 ml min-1 dl-1, P < 0.003 and P < 0.05, for AUC and maximal flow, one-way ANOVA, respectively). We concluded that Hp 2-2 diabetic patients had a worse EnF than controls and Hp 1-1 diabetic subjects.
AB - Endothelial function (EnF) is impaired in patients with diabetes mellitus (DM) due in large part to an increase in oxidative stress. Haptoglobin (Hp) is a potent antioxidant protein which is encoded by two different alleles (1 and 2) with the Hp 1 protein being a superior antioxidant to the Hp 2 protein. We hypothesized that DM individuals with the Hp 2-2 genotype would have greater endothelial dysfunction as compared to DM individuals with the Hp 1-1 genotype. We studied EnF in 16 Hp 2-2, 14 Hp 1-1 DM individuals and 14 healthy subjects. DM patients' groups were matched in terms of age, cardiovascular risk factors and metabolic characteristics. EnF was assessed using post-ischemic reactive hyperemia and strain gauge plethysmography and expressed either as the maximal flow after the ischemic period or as the area under the flow-time curve (AUC). We showed that EnF indices, AUC and maximal flow, were also higher in the healthy and Hp 1-1 groups compared with Hp 2-2 genotype group (615 ± 60 and 600 ± 40 vs. 450 ± 50 ml dl-1, 29 ± 2.6 and 25 ± 3 vs. 14 ± 1.8 ml min-1 dl-1, P < 0.003 and P < 0.05, for AUC and maximal flow, one-way ANOVA, respectively). We concluded that Hp 2-2 diabetic patients had a worse EnF than controls and Hp 1-1 diabetic subjects.
KW - Endothelial function
KW - Haptoglobin
KW - Reactive hyperemia
UR - https://www.scopus.com/pages/publications/67649344536
U2 - 10.1007/s00421-009-1048-z
DO - 10.1007/s00421-009-1048-z
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 19347351
AN - SCOPUS:67649344536
SN - 1439-6319
VL - 106
SP - 639
EP - 644
JO - European Journal of Applied Physiology
JF - European Journal of Applied Physiology
IS - 4
ER -